Paradigm Capital Management Inc Organon & Co. Transaction History

Paradigm Capital Management Inc

  • $2.21 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$10.95 - $17.32 $2.56 Million - $4.05 Million
234,000 Added 879.7%
260,600 $3.76 Million
Q3 2023

Nov 13, 2023
SELL
$16.59 - $23.77 $33,180 - $47,540
-2,000 Reduced 6.99%
26,600 $461,000
Q2 2023

Aug 14, 2023
SELL
$19.27 - $24.63 $924,960 - $1.18 Million
-48,000 Reduced 62.66%
28,600 $595,000
Q1 2023

May 12, 2023
BUY
$21.42 - $32.08 $1.64 Million - $2.46 Million
76,600 New
76,600 $1.8 Million

Others Institutions Holding OGN

# of Institutions
794
Shares Held
193M
Call Options Held
1.71M
Put Options Held
865K
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.06B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email